Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Motor Activity 2Breast Neoplasms 2Weight Loss 1Uterine Cervical Dysplasia 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Obesity 1Insulin Resistance 1Infertility, Female 1Infections 1Cognitive Dysfunction 1

Interventions

Exercise 24Metformin 23Resistance Training 8Nutrition Assessment 8Methods 8Tirzepatide 7Diet Therapy 7Diet 7Counseling 7Early Intervention, Educational 6Caloric Restriction 6Exenatide 5semaglutide 4Liraglutide 4Educational Status 4Docosahexaenoic Acids 4Diet, Mediterranean 4Vitamin D 3Therapeutics 3Surveys and Questionnaires 3Sugars 3Standard of Care 3Dexamethasone 3Yoga 2Tablets 2Specimen Handling 2Progestins 2Ovidrel 2Nutritional Status 2Naltrexone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Obesity × lime × Clear all
NCT05952882 2023-10-23

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Mỹ Đức Hospital

Phase 3 Unknown
188 enrolled
Other

Infertility, Female, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡